Trial Profile
A Study Evaluating long-Term Effect of Testosterone Undecanoate Therapy On Blood Pressure, Pulse Pressure And Heart Rate In Hypogonadal Men.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 May 2019
Price :
$35
*
At a glance
- Drugs Testosterone undecanoate (Primary)
- Indications Hypogonadism
- Focus Adverse reactions
- 18 Mar 2019 Results assessing improvements in quality of life In men With hypogonadism under long-term testosterone therapy (TTh) with testosterone undecanoate injections presented at the 101st Annual Meeting of the Endocrine Society
- 02 Jun 2016 New trial record
- 04 Apr 2016 Results presented at The 98th Annual Meeting of the Endocrine Society